Dolby Laboratories (Dolby Laboratories) ROCE %

: 11.35% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dolby Laboratories's annualized ROCE % for the quarter that ended in Dec. 2023 was 11.35%.

Dolby Laboratories ROCE % Historical Data

The historical data trend for Dolby Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dolby Laboratories Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

11.09

9.29

12.53

8.35

10.58

Dolby Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																15.42	17.55	3.74	3.37	11.35

Dolby Laboratories ROCE % Calculation

Dolby Laboratories's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	262.814	/	( ( (2689.548 - 277.518)	+	(2979.766 - 422.226) )	/ 2 )
	=	262.814	/	( (2412.03	+	2557.54)	/ 2 )
	=	262.814	/	2484.785
	=	10.58 %

Dolby Laboratories's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	289.248	/	( ( (2979.766 - 422.226)	+	(2935.529 - 394.096) )	/ 2 )
	=	289.248	/	( ( 2557.54	+	2541.433 )	/ 2 )
	=	289.248	/	2549.4865
	=	11.35 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Dolby Laboratories (NYSE:DLB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dolby Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories (Dolby Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

FUO:Germany FUO:Germany

Address

1275 Market Street, San Francisco, CA, USA, 94103-1410

Website

https://www.dolby.com

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Executives

Kevin J Yeaman	officer: VP, Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman	officer: EVP, GEN. COUN. & SECRTY	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling	officer: SVP, Entertainment	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton	officer: SVP, Chief Marketing Officer	1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud	director	C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian	director	DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher	director
Ryan Nicholson	officer: VP, Corporate Controller	C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar	officer: SVP, Advanced Technology Group	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet	director	9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park	officer: SVP & Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay	officer: Sr. Vice President, Research	1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew	officer: EVP, Chief Financial Officer	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103